USFDA Nod To Zydus Pharmaceuticals For OCD Treatment Drug

Region: Sector:
0
3
Pharma

Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clomipramine Hydrochloride capsules, used to treat obsessive compulsive

This content is restricted to site members. If you are an existing user, please log in. New users please check out our subscription options.

Existing Users Log In